Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Bijlsma JWJ, Welsing PMJ, Woodworth TG, Middelink LM, Pethö-Schramm A, Bernasconi C, Borm MEA, Wortel CH, Ter Borg EJ, Jahangier ZN, van der Laan WH, Bruyn GAW, Baudoin P, Wijngaarden S, Vos PAJM, Bos R, Starmans MJF, Griep EN, Griep-Wentink JRM, Allaart CF, Heurkens AHM, Teitsma XM, Tekstra J, Marijnissen ACA, Lafeber FPJ, Jacobs JWG. Bijlsma JWJ, et al. Among authors: van der laan wh. Lancet. 2016 Jul 23;388(10042):343-355. doi: 10.1016/S0140-6736(16)30363-4. Epub 2016 Jun 7. Lancet. 2016. PMID: 27287832 Clinical Trial.
Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.
Verhoeven AC, Boers M, te Koppele JM, van der Laan WH, Markusse HM, Geusens P, van der Linden S. Verhoeven AC, et al. Among authors: van der linden s, van der laan wh. Rheumatology (Oxford). 2001 Nov;40(11):1231-7. doi: 10.1093/rheumatology/40.11.1231. Rheumatology (Oxford). 2001. PMID: 11709606 Clinical Trial.
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, Geurts MA, van der Werf JH, van Albada-Kuipers GA, Jahangier-de Veen ZN, van der Veen MJ, Verhoef CM, Lafeber FP, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Bakker MF, et al. Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004. Ann Intern Med. 2012. PMID: 22393128 Free article. Clinical Trial.
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial.
Verhoef LM, den Broeder N, Thurlings RM, van der Laan WH, van der Weele W, Kok MR, Bernelot Moens HJ, Woodworth TG, van den Bemt BJF, van den Hoogen FHJ, den Broeder AA. Verhoef LM, et al. Among authors: van der laan wh. Lancet Rheumatol. 2019 Nov;1(3):e145-e153. doi: 10.1016/S2665-9913(19)30066-9. Epub 2019 Oct 23. Lancet Rheumatol. 2019. PMID: 38229391
Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease.
Pasma A, Schenk CV, Timman R, Busschbach JJ, van den Bemt BJ, Molenaar E, van der Laan WH, Schrauwen S, Van't Spijker A, Hazes JM. Pasma A, et al. Among authors: van den bemt bj, van t spijker a, van der laan wh. Arthritis Res Ther. 2015 Oct 8;17:281. doi: 10.1186/s13075-015-0801-4. Arthritis Res Ther. 2015. PMID: 26449852 Free PMC article.
29 results